Feed Your Portfolio With Dividends From ConAgra

This is the Jan. 27 Forbes Dividend Investor hotline:

After more than a year of rip-roaring stock market performance, dividend-paying stocks trading at bargain valuations are getting harder to find. Still, there are still some gems to be found with appropriate scouring the market.

Today's recommendation is one of the largest food companies in North America. Omaha, Neb.-based ConAgra Foods (CAG) is the company behind some of the most well-known consumer food brands, including Chef Boyardee, Healthy Choice, Hebrew National, Hunt's, Orville Redenbacher's, PAM, Peter Pan, Reddi-wip, Slim Jim, Snack Pack, Swiss Miss, Van Camp's and Wesson. Its Ralcorp division is a big player in private labeled and frozen foods.

Chef BOYARDEE MINI Ravioli (Credit: inazakira)

For the current fiscal year that ends in May, revenue is forecast to increase 14.1% to $17.67 billion. Earnings are expected to grow 8.3% to $2.34 per share, giving ConAgra shares a less-than-market price-earnings ratio of 14.1.

Dividends have been paid every quarter since 1985. ConAgra slashed the dividend in 2006, but over the past eight years, the quarterly payout has grown by about one penny per year to its current $0.25, good for a yield just above 3%.

Valuation makes a compelling case to buy. Since 2009, ConAgra has averaged a price-earnings multiple of 15.9. Multiplied by the $2.34 EPS forecast, that would yield a $37.20 stock price. As a multiple of sales, CAG looks similarly undervalued. Its average price-to-sales multiple over the past five years is 0.88, which would produce a $37 stock price based on the consensus forecast for just over $42 in revenue per share this year.

 John Dobosz is editor of Forbes Dividend Investor. Click here for a risk-free trial.

Best Medical Stocks To Own Right Now

Federal regulators are warning consumers to be on guard against potential marijuana-related stock scams.

NEW YORK (CNNMoney) You've probably seen one in your inbox or Facebook newsfeed: an email or posting advertising the next hot investment, with share prices that are sure to skyrocket soon!

With medical marijuana now legal in almost 20 states, shares of companies selling anything related to the drug are being touted as the latest "hot stocks." While such offers may sound tempting, federal regulators are warning they could actually be "pump and dump" stock scams.

Ultimate Guide to Retirement Getting started401(k)s & company plansInvestingAnnuitiesIRAsSelf-employment plansPensions and benefit plansSocial SecurityInsuranceEstate planningLiving in retirementGetting help

Spam emails related to such schemes, marijuana-related or otherwise, have spiked in the past year, the Financial Industry Regulatory Authority said recently.

Top 10 Growth Companies To Watch For 2015: Galectin Therapeutics Inc (GALT)

Galectin Therapeutics Inc., formerly Pro-Pharmaceuticals, Inc., incorporated on January 26, 2001, is a development-stage company. The Company is engaged in drug development to create therapies for cancer and fibrotic disease. As of December 31, 2011, the Company has two compounds in development, one is to be used in cancer therapy and the other intended to be used in the treatment of liver fibrosis and fatty liver disease. These two compounds are produced from different natural starting materials, both possessing the property, which lends itself to binding to and inhibiting galectin proteins. GM-CT-01, the Company's product candidate for cancer therapy, is a linear polysaccharide polymer consisted of mannose and galactose that has a defined chemical structure and is derived from a plant source. GR-MD-02, the Company's product for treatment of liver fibrosis and fatty liver disease with inflammation and fibrosis, is a polysaccharide polymer possessing both linear and globular structures, which also is derived from a plant source.

GM-CT-01 has in development for the therapy of colorectal cancer and is in a Phase I/II clinical trial as a combination therapy with a tumor vaccine in patients with advanced melanoma. Based on the completed Phase I and partially completed Phase II clinical trials, the Company is exploring two additional potential indicia for the use of GM-CT-01 in combination with cancer chemotherapy. There are two additional pathways for the development of GM-CT-01 for use in treatment of cancer. GM-CT-01 was found to be generally safe when studied in a Phase I clinical trial in end-stage cancer patients with multiple tumor types alone and in combination with 5-Fluorouracil (5-FU), which is an Food and Drug Administration (FDA)-approved chemotherapy used for treatment of various types of cancer.

Advisors' Opinion:

• [By Roberto Pedone]

   

  Galectin Therapeutics (GALT) offers drug research and development to create new therapies for fibrotic disease and cancer. This stock closed up 9.6% to $12.06 in Monday's trading session.

   

  Monday's Volume: 674,000
  
  Three-Month Average Volume: 222,171
  
  Volume % Change: 149%

   

  Shares of GALT jumped higher on Monday after Ascendiant initiated coverage on the stock with a buy recommendation.

   

   

  From a technical perspective, GALT spiked sharply higher here with strong upside volume. This stock has been uptrending for the last three months, with shares ripping higher from its low of $3.95 to its recent high of $13.21. During that move, shares of GALT have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of GALT within range of triggering a near-term breakout trade. That trade will hit if GALT manages to take out Monday's high of $12.44 and then once it clears its 52-week high at $13.21 with high volume.

   

  Traders should now look for long-biased trades in GALT as long as it's trending above some near-term support levels at $11 or at $10 and then once it sustains a move or close above those breakout levels with volume that hits near or above 222,171 shares. If that breakout hits soon, then GALT will set up to enter new 52-week-high territory above $13.21, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $16.

   

Best Medical Stocks To Own Right Now: FibroGen Inc (FGEN)

FibroGen, Inc. (FibroGen) is a research-based biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics to treat unmet medical needs. The Company focuses in the areas of fibrosis and hypoxia-inducible factor (HIF) biology. FibroGen�� products include Roxadustat (FG-4592), which is an oral small molecule inhibitor of HIF prolyl hydroxylases (HIF-PHs), in Phase III clinical development for the treatment of anemia in chronic kidney disease (CKD), and FG-3019, which is a monoclonal antibody in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), pancreatic cancer and liver fibrosis. The Company�� subsidiaries include FibroGen Europe Oy (FibroGen Europe) and FibroGen China Anemia Holdings, Ltd. (FibroGen China).

Roxadustat is the HIF-PH inhibitor in Phase III clinical development, which acts by stimulating the body�� natural pathway of erythropoiesis, or red blood cell production. Roxadustat represents a new paradigm for the treatment of anemia in CKD patients and offers injectable erythropoiesis stimulating agents (ESAs). 1,449 subjects have participated in 26 completed Phase I and II clinical studies for roxadustat in North America, Europe and Asia. The Company, along with its collaboration partners, Astellas Pharma Inc., (Astellas) and AstraZeneca AB,(AstraZeneca), has designed a global Phase III program to support regulatory approval of roxadustat in both NDD-CKD and DD-CKD patients in multiple geographies.

FG-3019 is the Company�� fully-human monoclonal antibody that inhibits the activity of connective tissue growth factor (CTGF), a critical common element in the progression of fibrosis and associated diseases. In Phase II IPF clinical studies, FG-3019 demonstrated the stabilization of disease and, in human studies, reversal of lung fibrosis in some patients. In an open-label Phase II pancreatic cancer study of FG-3019 plus gemcitabine and erlotinib, FG-3019 demonstrated a dose-depen! dent improvement in one year survival rate. In 10 Phase I and Phase II clinical studies of FG-3019 to date involving over 340 subjects, FG-3019 has been tolerated across a range of doses studied, and there have been no dose-limiting toxicities observed as of November 13, 2014.

The Company competes with Threshold Pharmaceuticals, Inc., Gilead Sciences, Inc., Halozyme Therapeutics, Inc., Gilead Sciences, Inc., Celgene Corporation, Janssen Biotech, Inc., Johnson & Johnson, Inc., Sanofi, Novartis and Biogen Idec.

Advisors' Opinion:

• [By John Udovich]

  Recent IPO�FibroGen Inc (NASDAQ: FGEN) surged 22.96% today, reportedly after the journal Hepatology published the results of a workshop between the FDA and the American Association for the Study of Liver Disease (AASLD) which laid out criteria for a phase three study of a treatment for non-alcoholic steatohepatitis (NASH)���meaning its worth taking a closer look at the stock along with the performance of potential small cap or mid cap liver disease stock peers like Conatus Pharmaceuticals Inc (NASDAQ: CNAT), Intercept Pharmaceuticals Inc (NASDAQ: ICPT) and Raptor Pharmaceutical Corp (NASDAQ: RPTP) which rose 24.35%, 10.98% and 2.02%, respectively. According to Investors Business Daily, NASH (the more serious version of fatty liver disease) is potentially an enormous market with about 6 million�US patients but the�lack of previous treatments had left it unclear how the FDA would measure success against the disease while FibroGen Inc doesn't yet have a NASH human trial in the works, it has said it hopes to start one for its lead candidate FG-3019 (its in mid-stage trials for pulmonary fibrosis and liver fibrosis due to hepatitis B infection).

Best Medical Stocks To Own Right Now: SearchCore Inc (SRER)

SearchCore, Inc., formerly General Cannabis, Inc., incorporated in 2003, is a technology service provider. As of December 31, 2011, the Company was engaged in the medicinal cannabis industry. The Company assists the physicians, dispensaries, and end-users within the medicinal cannabis industry in finding each other and in advertising their businesses. All of its operations are conducted through its wholly owned subsidiaries. On January 5, 2012, WeedMaps, LLC (WeedMaps) acquired substantially all the assets of MMJMenu, LLC. On October 31, 2011, General Merchant Solutions, Inc. discontinued all retail credit card processing operations. On January 11, 2011, the Company acquired all the assets of Revyv, LLC. On December 31, 2012, the Company acquired Sports Asylum, Inc. In February 2013, it acquired ModularHomes.com.

WeedMaps Media, Inc. is its wholly owned subsidiary, and its primary operation is the Internet Website, www.weedmaps.com. WeedMaps.com is an online finder site service that allows patients to find local medical cannabis dispensaries, which are also referred to as collectives. Dispensaries are locations where patients who have received letters of recommendation from a healthcare provider can purchase medicinal cannabis, as well as a variety of other non-cannabis related items including, but not limited to, apparel accessories, posters, bumper stickers, concert tickets, books and musical compact disc�� (CD��).

General Marketing Solutions, Inc. is its wholly owned subsidiary, and its primary operation is the Internet Website, www.cannabiscenters.com. General Management Solutions, Inc. is its wholly owned subsidiary that oversees and provides all of the human resources issues for employees, including hiring, terminating and employee benefits. The Company has two additional wholly owned subsidiaries; General Processing Corporation, CannaCenters Corporation (CannaCenters), and two subsidiaries, namely LV Luxuries Incorporated (which operated as makeup.com) and General ! Health Solutions, Inc. (CannaCenters.com).

Advisors' Opinion:

• [By Peter Graham]

  Small cap communications or Internet stocks American Community Development Group Inc (OTCMKTS: ACYD), Globalstar, Inc (OTCMKTS: GSAT) and SearchCore Inc (OTCMKTS: SRER) have been rather quiet lately for investors after making some noise back in September. Nevertheless, all three are still getting some mentions in various investment newsletters or alerts and not because they are the subject of paid promotions. So are these small cap stocks about to make some noise? Here is a closer look:

Best Medical Stocks To Own Right Now: Tonix Pharmaceuticals Holding Corp (TNXP)

Tonix Pharmaceuticals Holding Corp., incorporated on November 16, 2011, is a specialty pharmaceutical company focused on developing novel pharmaceutical products for disorders of the central nervous system (CNS). The Company develops TNX-102 sublingual tablet, or TNX-102 SL. TNX-102 SL is a novel dose and formulation of cyclobenzaprine (CBP), the active pharmaceutical ingredient of two prescribed muscle relaxant products, Flexeril and Amrix. TNX-102 SL is also intended for chronic use. It develops TNX-102 SL for the treatment of FM under a United States Investigational New Drug application (IND), and under three clinical trial applications (CTAs), filed in Canada. It also develops TNX-102 SL for the treatment of post-traumatic stress disorder (PTSD). As of January 25, 2013, the Company focuses on product development, and had not generated any revenues.

The Company searches for potential therapeutic solutions among known pharmaceutical agents that lack regulatory approval for the indications it seeks, but may be approved for use in other indications. It seeks to create new dose and formulation options that are tailored to the therapeutic uses to which it applies these agents. TNX-102 SL is a small, rapidly disintegrating tablet containing CBP for sublingual administration at bedtime. The Company designed TNX-102 SL for delivery of CBP to the systemic circulation through sublingual transmucosal absorption and to avoid first-pass liver metabolism.

CBP is the active pharmaceutical ingredient in its lead product candidate, TNX-102 SL. In addition to CBP, TNX-102 SL contains inactive ingredients, called excipients, which are approved for pharmaceutical use. In addition to TNX-102 SL, it develops other formulations of CBP, including TNX-102 promicellar gelatin capsule, or TNX-102 gelcap. It developed TNX-102 gelcap under an agreement with Lipocine, Inc. (Lipocine), a contract formulation developer and small-scale manufacturer. In addition it has other pipeline of other product cand! idates, including TNX-201 and TNX-301. TNX-201 is based on isometheptene mucate and is under development as a treatment for certain types of headaches.

Advisors' Opinion:

• [By John Kell]

  Tonix Pharmaceuticals Holding Corp.(TNXP) is planning to offer some shares to raise money to fund clinical trials and the continued development of the specialty pharmaceutical company’s treatments. Shares edged up 2.1% to $16.75 premarket.

Best Medical Stocks To Own Right Now: Aethlon Medical Inc (AEMD)

Aethlon Medical, Inc. (Aethlon), incorporated on April 17, 1991, is a developmental-stage company. The Company is focused on creating medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions.

The Company's Aethlon ADAPT (Adaptive Dialysis-Like Affinity Platform Technology) system is a revenue-stage technology platform that provides the basis for a new class of devices that provide rapid, selective removal of disease promoting particles from the entire circulatory system. The Aethlon ADAPT product pipeline includes the Aethlon Hemopurifier to address infectious disease and cancer, and a medical device being developed under the Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers.

The Aethlon Hemopurifier

The Company's Hemopurifier is a medical device that targets the rapid elimination of life-threatening infectious disease and cancer glycopathogens from circulation. Under the feasibility study protocol, the Company will enroll ten end-stage renal disease (ESRD) patients who are infected with the Hepatitis C virus (HCV) to demonstrate the safety of Hemopurifier therapy. In addition to augmenting the early viral kinetic response to SOC, the Company's Hemopurifier provides a candidate solution for viral rebound patients who traditionally are forced to discontinue therapy at the point HCV establishes resistance to drug regimens. Additionally, the Company's Hemopurifier represents a therapeutic strategy to address the population of HCV-infected dialysis patients for which SOC and all-antiviral strategies may be contraindicated or not cleared.

In design, the Company's Hemopurifier consists of the affinity lectin Galanthus nivalis agglutinin (GNA) immobilized in the outer-capillary space of advanced plasma membrane technology. The design allows for extracorporeal therapeutic delivery to occur on standard CRRT and dialysis instruments alre! ady located in hospitals and clinics worldwide. The mechanism of the Hemopurifier to rapidly eliminate a broad-spectrum disease targets is based on GNA�� ability to selectively bind high mannose signatures that are abundant on the surface of cancer-secreted exosomes and glycoproteins that reside on the outer membrane of infectious viral pathogens. The Company has also established a compassionate-use treatment program at the Medanta Medicity Institute in India that provides treatment access to HCV-infected individuals.

The Company's Hemopurifier has also been discovered to capture tumor-secreted exosomes underlying several forms of cancer. Tumor-derived exosomes have recently emerged to be a vital therapeutic target in cancer care. These microvesicular particles suppress the immune response in cancer patients through apoptosis of immune cells and their quantity in circulation correlates directly with disease progression. In addition to treating HCV-infected individuals, the Company has conducted a single proof of principal treatment study related to the treatment of HIV. In the study, Hemopurifier therapy reduced viral load by 93% in an HIV-AIDS infected individual without the administration of antiviral drug therapy. The study protocol provided for 12 Hemopurifier treatments, each four hours in duration, that were administered over the course of one month. Researchers at a university have since discovered that the Hemopurifier is able to capture exosomes that transport NEF protein, which is known to suppress the immune response in HIV-infected individuals.

The Company has been assigned all rights and title to and interests in an invention and related worldwide patent rights for a method to treat cancer under an assignment agreement with the London Health Science Center Research, Inc. (LHSCRI) The agreement provides that the Company is responsible for paying certain patent application and filing costs as well as a 2% royalty on any future net sales. The Company has als! o exercis! ed an option to license a pending patent entitled, Method to Inhibit Proliferation and Growth of Metastases from The Trustees of Boston University. The license provides a development strategy for new cancer therapies by uniting drug agents that inhibit the spread of cancer-related metastases with filtration techniques already in the Aethlon Hemopurifier(R). The resulting devices would inhibit tumor growth by reducing the presence of circulating growth factors without interfering with surgical wound healing or the recovery of tissue injured by radiation therapy.

The Company competes with Asahi Kasei Kurary Medical.

Advisors' Opinion:

• [By James E. Brumley]

  Stocks as a whole haven't gotten the new year off on the best foot, but that's not to say every equity out there is in trouble. Indeed, some small cap stocks may actually be doing well - and poised to do well for a while - specifically because larger companies are seeing their stocks struggle. To that end, traders looking for a bullish bright spot to start the new year may want to take a closer look at Amedica Corporation (NASDAQ:AMDA), Threshold Pharmaceuticals, Inc. (NASDAQ:THLD), and Aethlon Medical, Inc. (OTCMKTS:AEMD).

Best Medical Stocks To Own Right Now: Spectral Diagnostics Inc (DIAGF)

Spectral Diagnostics Inc. (Spectral), incorporated on July 29, 1991, focuses on the development and commercialization, in North America, treatment for severe sepsis and septic shock. The Company also manufactures and sells certain reagents. Its products include Rapid Diagnostics for Sepsis, Endotoxin Activity Assay (EAA) and Toraymyxin. As of December 31, 2011, Spectral�� EAA endotoxin measurement was the only the United Sates Food and Drug Administration (FDA) cleared diagnostic on the market. Spectral Diagnostics (US) Inc. and Spectral Diagnostics (New Brunswick) Inc. are its subsidiaries.

The Company has developed a rapid diagnostic test for detection of components of gram negative bacterial cell wall (endotoxin). The EAA instrument is manufactured under contract for use in the hospital setting. The Toraymyxin hemoperfusion device removes endotoxin from the bloodstream and is manufactured by Toray Industries Inc. of Japan. The product is sold in Japan and Europe and has been used over 80,000 patients worldwide. As of December 31, 2011, Spectral was conducting clinical trials for the purpose of seeking regulatory approval in the United States. Spectral develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies. Royalty revenues are earned from these license arrangements based on a percentage of end user sales of Troponin I.

The Company competes with Eli Lilly, Agennix AG, AstraZeneca, Eisai, Gambro, InflammaGen Therapeutics, Fresenius and CytoSorbents.

Advisors' Opinion:

• [By maarnio]

  Spectral Diagnostics (DIAGF) develops and commercializes theranostic treatment for severe sepsis in North America.

  Shares outstanding (March 31, 2014)

Best Medical Stocks To Own Right Now: NeoStem Inc (NBS)

NeoStem, Inc., incorporated on September 18, 1980, operates in cellular therapy industry. Cellular therapy addresses the process by which new cells are introduced into a tissue to prevent or treat disease, or regenerate damaged or aged tissue, and consists of a separate therapeutic technology platform in addition to pharmaceuticals, biologics and medical devices. The Company�� business model includes the development of novel cell therapy products, as well as operating a contract development and manufacturing organization (CDMO) providing services to others in the regenerative medicine industry. Progenitor Cell Therapy, LLC, the Company�� wholly owned subsidiary (PCT), is a CDMO in the cellular therapy industry. PCT has provided pre-clinical and clinical current Good Manufacturing Practice (cGMP) development and manufacturing services to over 100 clients advancing regenerative medicine product candidates through rigorous quality standards all the way through to human testing.

PCT has two cGMP, cell therapy research, development, and manufacturing facilities in New Jersey and California, serving the cell therapy community with integrated and regulatory compliant distribution capabilities. Its core competencies in the cellular therapy industry include manufacturing of cell therapy-based products, product and process development, cell and tissue processing, regulatory support, storage, distribution and delivery and consulting services. The Company�� wholly-owned subsidiary, Amorcyte, LLC (Amorcyte) is developing its own cell therapy, AMR-001, for the treatment of cardiovascular disease. AMR-001 represents its clinically advanced therapeutic product candidate and enrollment for its Phase II PreSERVE clinical trial to investigate AMR-001's safety and efficacy in preserving heart function after a heart attack in a particular type of post Acute Myocardial Infarction (AMI) patients.

Through the Company�� subsidiary, Athelos Corporation (Athelos), the Company is collaborating w! ith Becton-Dickinson in early stage clinical development of a therapy utilizing T-cells, collaborating for autoimmune and inflammatory conditions, including but not limited to, graft vs. host disease, type 1 diabetes, steroid resistant asthma, lupus, multiple sclerosis and solid organ transplant rejection. The Company�� pre-clinical assets include its Very Small Embryonic Like (VSEL) Technology platform. The Company has basic research and development capabilities, manufacturing facilities on both the east and west coast of the United States.

Advisors' Opinion:

• [By John Udovich]

  The results of a recent Pew Center Poll regarding attitudes towards abortion and various forms of stem cell research could be a good sign for the stem cell industry along with small cap stem cell stocks like StemCells Inc (NASDAQ: STEM), NeoStem Inc (NASDAQ: NBS), Neuralstem, Inc (NYSEMKT: CUR),�International Stem Cell Corp (OTCMKTS: ISCO) and BioRestorative Therapies (OTCBB: BRTX). Basically, Americans think that having an abortion is a moral issue with 49% of American adults believing abortion is morally wrong, 23%�view it not as a moral issue and and 15% view it as morally acceptable. However and when Americans were asked about issues surrounding�human embryos, such as stem cell research or in vitro fertilization, as a matter of morality, their views were different.

Best Performing Stocks To Buy For 2014

The wealth-building power of compound interest will never cease to amaze me. But a soft dividend can also distract investors from exciting growth opportunities. There are times when a weak payout may be all right, because the company is building a larger and stronger cash machine to fund payouts in the decades ahead.

Walt Disney (NYSE: DIS  ) rarely comes up in discussions of brilliant dividend plays. The media giant's measly 1.1% yield is hardly the stuff of legend, and Disney spends just 26% of its free cash on dividend checks. That's less than half the average Dow Jones (DJINDICES: ^DJI  ) cash payout ratio of 57%. With this much headroom to increase payouts, why doesn't the House of Mouse turn up the heat under its dividend policy? Does this company hate shareholders?

The short answer to that rhetorical question is, of course, a resounding "no."

For one thing, Disney is getting over its reluctance to raise dividends lately. Thanks to large increases in 2011 and 2012, Disney's payouts have more than doubled in the last five years. The main reason why this trend didn't unlock a generous yield is simple: The stock is just performing too darn well! It's hard to keep a dividend policy abreast with the rapid rise of Disney share prices.

Top 5 Services Stocks To Own Right Now: CollabRx Inc (CLRX)

CollabRx, Inc., incorporated on September 20, 1995, is focused on developing and delivering content knowledge-based products and services that inform healthcare decision-making, with an emphasis on genomics-based precision medicine and big data analytics. The Company delivers content to users through Web-based applications and services in the cloud serving physicians and their patients in two settings: at the point-of-care in the clinic and indirectly, as a part of a genetic test report provided to an ordering physician by a diagnostic testing laboratory, (lab). The Company�� Therapy Finder Web-based application serves as an initial user-interface to the underlying knowledge base. It is available free of charge on its Website. In addition, a professional version is offered to registered physicians through MedPage Today, an offering of Everyday Health, Inc.

The Company�� offering provides the clinical interpretation of genetic variants present in human tumor biopsies, and is sold directly to diagnostic labs that perform molecular testing on patients. Its Genetic Variant Application (GVA) is compiled by its software platform to provide specific insights to a patient�� diagnostic test results on a test-by-test basis. The GVA results are provided to laboratories in a variety of forms, including with a front-end user Interface (UI) or directly integrated into a customer�� laboratory information management system (LIMS). The Company�� content is identified as Powered by CollabRx within the test report. Portions of its Web-based applications are available free to physicians and patients through commercial on-line media partners under a license and advertising or sponsorship revenue sharing arrangement. The content that, the Company offers to laboratories is sold based on a variation of Software as a service (SaaS) business model, in which its content is provided on a one-time, subscription or per test basis. It also receives fee-for-service payments in connection with customized user ! interfaces to its database.

Advisors' Opinion:

• [By Bryan Murphy]

  It's yet another case of technology converging with healthcare, though truth be told, the Bridgeline only scratches the surface of how the digital world and the patient-care world can unite to create something greater than the sum of its parts. A little company called CollabRx Inc. (NASDAQ:CLRX) is taking it up a notch - maybe two notches - to turn the web into a guidance portal for oncologists seeking new and better treatment options for cancer patients. Among these options are drug trials that a caregiver may not even be aware of, were it not for this highly-specialized site CLRX has designed.

• [By Bryan Murphy]

  Eat your heart out Foundation Medicine Inc. (NASDAQ:FMI). And WebMD Health Corp. (NASDAQ:WBMD)? Don't even bother trying. CollabRx Inc. (NASDAQ:CLRX) has built a better mousetrap, and if yesterday's announcement is a sign of things to come, CLRX could prove to be a very compelling investment.

• [By James E. Brumley]

  What do you get when you combine 10,000 different clinical trials trying out 500 cancer drugs against a backdrop of 100,000 new white papers on the topic published every year? In a perfect world all that stuff would almost seem like the foundation for an outright cure for cancer. In reality though, all that data is a recipe for a confusing mess. Thank goodness CollabRx Inc. (NASDAQ:CLRX) is on the scene, straightening out the maddening mess.

Best Performing Stocks To Buy For 2014: EMS Seven Seas ASA (EMS)

EMS Seven Seas ASA, formerly known as Eitzen Maritime Services ASA, is a Norway-based company active in the shipping industry. It is operational through two divisions: Ship Management and Ship Supply, servicing clients within the military, merchant, fisheries, offshore and cruise market segments. The Ship Management (and Insurance) unit provides technical management, crewing, newbuilding and project consultancy services, ship agency services and marine insurance brokering. It has its main operations in the Baltic, Russia, India and Singapore. Ship Supply provides provisions, duty free products, stores, spares and marine products and equipment to the merchant marine, offshore, fishing fleet, military and cruise market. This segment operates in Norway, Germany, the Netherlands, Spain, the United Arab Emirates (UAE), Djibouti and Singapore. Eitzen Maritime Services ASA is active internationally through its subsidiaries. Advisors' Opinion:

• [By victorselva]

  In a macro view, revenues in the electronic equipment and instrument sub-industry will remain strong due to the rise in equipment and instrument manufacturers. Distributors, electronic manufacturing service (EMS) companies and original equipment manufacturers (OEM) are going to increase orders as the economy improves in the future. With this promising outlook, let's take a look at Gabelli麓s last trade and try to explain to investors the reasons of this appealing investment opportunity.

Best Performing Stocks To Buy For 2014: Adecco SA (ADEN)

Adecco SA is a Switzerland-based holding company and provider of human resource services, including temporary staffing, outsourcing, permanent placement, outsourcing, outplacement and career management, training and consulting. The Company divides its activities into two main sectors: General Staffing and Professional Staffing. The General Staffing sector, which is the Company's prime segment, is divided into two business lines: Adecco Office, which includes Adecco Office and Office Angels brands, and Adecco Industrial, including Adecco, Adecco Industrial and Tuja brands. The Professional Staffing sector is divided into four business lines: Information Technology, including Modis and Computer People brands; Engineering & Technical, including Adecco Engineering & Technical, Entegee and euro engineering brands; Finance & Legal, including Badenoch & Clark and Accounting Principals brands, and Medical & Science, including Soliant and Adecco Medical brands. Advisors' Opinion:

• [By Corinne Gretler]

  ��decco fulfilled expectations on all levels,��Patrick Hasenboehler, an analyst at J. Safra Sarasin in Zurich, wrote in a report to clients. ��he outlook statement is quite promising. Adecco (ADEN)�� strategy of focusing on profitability will continue to pay off.��

Best Performing Stocks To Buy For 2014: Vanguard Short-Term Bond ETF (BSV)

Vanguard Short-Term Bond ETF (the Fund) seeks to track the performance of a market-weighted bond index with a short-term, dollar-weighted average maturity. The Fund employs a passive management or indexing strategy designed to track the performance of the Barclays Capital U.S. 1-5 Year Government/Credit Bond Index (the Index). The Index includes all medium and larger issues of the United States Government, investment-grade corporate, and investment-grade international dollar-denominated bonds that have maturities of between 1 and 5 years and are publicly issued. The Fund invests by sampling the Index, meaning that it holds a range of securities that, in the aggregate, approximates the full Index in terms of key risk factors and other characteristics. All of the Fund�� investments will be selected through the sampling process, and at least 80% of its assets will be invested in bonds held in the Index. The Fund�� investment advisor is The Vanguard Group, Inc. Advisors' Opinion:

• [By GURUFOCUS]

  In addition to individual stocks several funds pay a monthly dividend. Below is a sampling of these:
  Monthly Bond Funds- iShares Barclays 1-3 Year Credit Bond (CSJ) | Yield: 1.29%
  - Vanguard Short-Term Bond ETF (BSV) | Yield: 1.25%
  - Vanguard Intermediate-Term Bond ETF (BIV) | Yield: 2.96%
  - Vanguard Long-Term Bond ETF (BLV) | Yield: 4.42%

Best Performing Stocks To Buy For 2014: Computer Task Group Inc (CTG)

Computer Task Group, Incorporated (CTG), incorporated on March 11, 1966, is an information technology (IT) solutions and staffing company with operations in North America and Europe. CTG provides IT services to its clients, which includes IT Solutions and IT Staffing. During the year ended December 31, 2011, the Company had six operating subsidiaries: Computer Task Group of Canada, Inc., providing services in Canada; and Computer Task Group Belgium N.V., CTG ITS S.A., Computer Task Group IT Solutions, S.A., Computer Task Group Luxembourg PSF, and Computer Task Group (U.K.) Ltd., each were providing services in Europe. Services provided in North America are performed by CTG. It provides services to all of the markets, which it serves. The services provided encompass the IT business solution life cycle, including phases for planning, developing, implementing, managing, and maintaining the IT solution. In February 2013, it acquired etrinity from i-Cros Nv of Antwerp, Belgium.

The Company promotes its services through four vertical market focus areas: technology service providers; healthcare, which includes services provided to healthcare providers, health insurers (payers), and life sciences companies; energy, and financial services. At December 31, 2011, CTG provided IT services to approximately 300 clients in North America and Europe. In North America, the Company operates in the United States and Canada. In Europe, the Company operates in Belgium, Luxembourg, and the United Kingdom.

IT Solutions

CTG�� services in IT solution area include helping clients assess their business needs and identifying the IT solutions. The services delivered by the Company include the selection and implementation of packaged software and the design, development, testing, and integration of new systems, and the development and implementation of customized software and solutions designed to fit the needs of a specific client or vertical market. Also included in IT Solutions is Trans! itional Application Management (TAM).

In 2011, the healthcare market accounted for most of CTG�� TAM business. In 2011, CTG continued to invest in new IT solutions development, primarily targeted to the healthcare market, which support cost reductions and productivity improvements. In 2011, several healthcare solutions under development moved from the pilot stage of testing using live data into the sales process as completed tools. These solutions include medical fraud, waste, and abuse detection and reduction, medical care and disease management, and group insurance underwriting risk assessment. The Company has developed software to support these offerings. These solutions support both the healthcare provider and payer markets.

IT Staffing

The Company recruits, retains, and manages IT talent for its clients, which are technology service providers and companies with multiple locations and need for external IT resources. The Company also supports companies and organizations that need to augment their own IT staff on a flexible basis. It provides IT talent services on a temporary or long-term basis. CTG�� recruiting organization works with customers to define their staffing requirements. The primary focus of the Company�� staffing business is a managed services model that provides clients with support through supply models customized to client needs, resource management support, vendor management programs, and a automated recruiting process and system. During 2011, its IT staffing service generated 63% of its total revenue.

Advisors' Opinion:

• [By Seth Jayson]

  Computer Task Group (Nasdaq: CTG  ) reported earnings on July 22. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended June 28 (Q2), Computer Task Group missed estimates on revenues and met expectations on earnings per share.

Best Casino Stocks To Invest In 2014

This week, Cesear's Palace became the first casino to ban Google (NASDAQ: GOOG  ) Glass. The ban comes from a more broad law in Nevada that says that the use of recording devices and computers isn't allowed when gambling. Similarly, movie theaters ban recording devices, and recently even a bar in Seattle banned users from using the device while enjoying a drink.

Not surprisingly, lawmakers have already jumped into the Glass fray, and some, such as West Virginia state official Gary G. Howell have proposed bans on wearing the device while driving. And just a few days ago, a group of House members sent a letter to Google's Larry Page, requiring answers by June 14 on how Google will incorporate privacy protections into Google Glass.

But is this really a brave new world we need to protect ourselves from, or just more of what we already have, repackaged into a different design?

Top 10 US Stocks To Invest In 2015: Sands China Ltd (SCHYF)

Sands China Ltd. (Sands China) is an investment holding company. The Company, along with its subsidiaries, is engaged in the development and operation of integrated resorts in Macao, which contain not only gaming areas, but also meeting space, convention and exhibition halls, retail and dining areas and entertainment venues. The Company operates in five segments: The Venetian Macao, Sands Macao, The Plaza Macao, Sands Cotai Central and ferry and other operations. The Venetian Macao, the Plaza Macao and Other developments derive their revenue primarily from casino, hotel, food and beverage, mall, convention, retail and others sources. Ferry and other operations derive their revenue from the sale of ferry tickets for transportation between Hong Kong and Macau. As of December 31, 2011, its properties included 3,554 hotel rooms and suites, 74 restaurants, 1.2 million square feet of retail, 1.2 million square feet of meeting space, two permanent theaters, a 15,000-seat arena and the casino. Advisors' Opinion:

• [By MARKETWATCH]

  HONG KONG (MarketWatch) -- Hong Kong stocks sold off early Thursday after the Federal Reserve decided to further taper stimulus, and after a final reading of China's manufacturing PMI contracted. The Hang Seng Index (HK:HSI) sank 1.5% to 21,815.04 in holiday-shortened trading. Tech stocks retreated, as Chinese PC maker Lenovo Group Ltd. (HK:992) (LNVGF) dropped 5.3%, failing to get a lift from news that it plans to acquire the Motorola handset business from Google Inc. (GOOG) for $2.91 billion as Lenovo aims for a bigger presence in the U.S. market. Software developer Kingsoft Corp. (HK:3888) (KSFTF) fell 1.9% and Internet giant Tencent Holdings Ltd. (HK:700) (TCTZF) dropped 1.5%. Casino stocks also declined. Sands China Ltds. (HK:1928) (SCHYF) , the Hong Kong-listed unit of Las Vegas Sands Corp. (LVS) , slipped 0.2%, despite financial results that showed Sands China's net income increased 40% year-on-year to $467 million in the fourth quarter. Melco Crown Entertainment Ltd. (HK:6883) (MPEL) slumped 3.2%, and both Wynn Macau Ltd. (HK:1128) (WYNMF) and MGM China Holdings Ltd. (HK:2282)

• [By MARKETWATCH]

  HONG KONG (MarketWatch) -- Hong Kong stocks rose early Wednesday, with the Hang Seng Index (HK:HSI) up 0.2% at 22,587.72. Hong Kong properties advanced, as the city's major developer Sun Hung Kai Properties Ltd. (HK:16) (SUHJY) rose 0.7%, after the company launched new luxury Riva project and saw the first batch of 64 flats sold out on the first day of sale. Sino Land Co. (HK:83) (SNLAF) rose 1.1%, Cheung Kong (Holdings) Ltd. gained 0.9%, and Henderson Land Development Co. (HK:12) (BACHY) edged up 0.2%. Chinese auto maker Dongfeng Motor Group Co. (HK:489) resumed trading and fell 0.9%, after the company said it signed an agreement with French joint-venture partner PSA Peugeot Citroen to invest 800 million euros ($1.1 billion) for a stake in the company. Most Casino stocks were lower, after reports said Macau planned to cut the duration of operators' licenses to 5 years. Shares of MGM China Holdings Ltd. (HK:2282) (MCHVF) declined 1.6%, SJM Holdings Ltd. (HK:880) lost 1%, and Sands China Ltds. (HK:1928) (SCHYF) dropped 0.8%. On the mainland, the Shanghai Composite Index (CN:SHCOMP) traded flat at 2,119.77.

Best Casino Stocks To Invest In 2014: MGM Resorts International(MGM)

MGM Resorts International, through its subsidiaries, primarily owns and operates casino resorts in the United States. The company?s resorts offer gaming, hotel, dining, entertainment, retail, and other resort amenities. It also owns and operates golf courses and a golf club. As of December 31, 2010, the company owned and operated 15 properties located in Nevada, Mississippi, and Michigan; and has 50% investments in 4 other casino resorts in Nevada, Illinois, and Macau. In addition, MGM Resorts International has an agreement with the Mashantucket Pequot Tribal Nation, which owns and operates a casino resort in Connecticut, to carry the ?MGM Grand? brand name. The company was formerly known as MGM MIRAGE and changed its name to MGM Resorts International in June 2010. MGM Resorts International was founded in 1986 and is based in Las Vegas, Nevada.

Advisors' Opinion:

• [By Jayson Derrick]

  Analysts at Ascendiant Capital initiated coverage of MGM Resorts (NYSE: MGM) with a Buy rating and $33 price target. Shares hit new 52 week highs of $28.74 before reversing gains and closing the day at $28.31, down 0.28 percent.

Best Casino Stocks To Invest In 2014: Bwin.Party Digital Entertainment PLC (BPTY)

bwin.party digital entertainment plc (bwin.party) is a holding company. The Company is an online gaming company. It operates in five segments: sports betting, casino & games, poker, bingo; and other (including network services, World Poker Tour, InterTrader.com, WIN.com, software services and the payment services business). Its sport betting segment includes bwin, betoto, Gamebookers, Gioco Digitale and PartyBets. It�� Casino & games segment includes PartyCasino, bwin and GD Casino. Its poker segment includes PartyPoker, bwin and GD Casino. Its Bingo segment includes Foxy Bingo, Cheeky Bingo, Gioco Digitale and Binguez. The Company�� subsidiaries include BES SAS, bwin Argentina SA, bwin Italia S.r.l., bwin.party Games AB and Cashcade Limited. Its subsidiaries are engaged in management and information technology (IT) services, marketing services, online gaming, transaction services, customer support services, marketing support services and Land-based poker events. Advisors' Opinion:

• [By Namitha Jagadeesh]

  Bwin.Party Digital Entertainment Plc (BPTY) plunged 14 percent to 110 pence, the biggest drop since April 2011, after the online gaming company said 2013 sales will be 14 percent to 17 percent lower than last year�� figures. Analysts on average had forecast a sales drop of 9.2 percent.

Best Casino Stocks To Invest In 2014: Wynn Macau Ltd (WYNMF)

Wynn Macau, Limited is a holding company. The Company, along with its subsidiaries, is a developer, owner and operator of destination casino gaming and entertainment resort facilities in Macau. Its operating subsidiary, Wynn Resorts (Macau) S.A. (WRM), owns and operates destination casino resort Wynn Macau in Macau. As of December 31, 2011, it had 265,000 square feet of casino space, offering 24-hour gaming with a range of games, and two luxury hotel towers with 1,008 spacious rooms and suites. It also offers eight casual and fine dining restaurants, 54200 square feet of stores and boutiques, such as Bvlgari, Chanel, Dior, Gucci, Hermes, Hugo Boss, Louis Vuitton, Miu Miu, Piaget, Prada, Rolex, Tiffany, Vacheron Constantin, Van Cleef & Arpels, Versace, Vertu and others, two health clubs and spas, a salon, a pool, and lounges and meeting facilities. As of December 31, 2011, its subsidiaries included Wynn Resorts International, Ltd., Wynn Resorts (Macau) Holdings, Ltd. and others. Advisors' Opinion:

• [By MARKETWATCH]

  HONG KONG (MarketWatch) -- Hong Kong stocks sold off early Thursday after the Federal Reserve decided to further taper stimulus, and after a final reading of China's manufacturing PMI contracted. The Hang Seng Index (HK:HSI) sank 1.5% to 21,815.04 in holiday-shortened trading. Tech stocks retreated, as Chinese PC maker Lenovo Group Ltd. (HK:992) (LNVGF) dropped 5.3%, failing to get a lift from news that it plans to acquire the Motorola handset business from Google Inc. (GOOG) for $2.91 billion as Lenovo aims for a bigger presence in the U.S. market. Software developer Kingsoft Corp. (HK:3888) (KSFTF) fell 1.9% and Internet giant Tencent Holdings Ltd. (HK:700) (TCTZF) dropped 1.5%. Casino stocks also declined. Sands China Ltds. (HK:1928) (SCHYF) , the Hong Kong-listed unit of Las Vegas Sands Corp. (LVS) , slipped 0.2%, despite financial results that showed Sands China's net income increased 40% year-on-year to $467 million in the fourth quarter. Melco Crown Entertainment Ltd. (HK:6883) (MPEL) slumped 3.2%, and both Wynn Macau Ltd. (HK:1128) (WYNMF) and MGM China Holdings Ltd. (HK:2282)

Best Casino Stocks To Invest In 2014: Pinnacle Entertainment Inc.(PNK)

Pinnacle Entertainment, Inc. owns, develops, and operates casinos, and related hospitality and entertainment facilities in the United States. It operates casinos, such as L'Auberge du Lac in Lake Charles, Louisiana; River City Casino and Lumiere Place in St. Louis, Missouri; Boomtown New Orleans in New Orleans, Louisiana; Belterra Casino Resort in Vevay, Indiana; Boomtown Bossier City in Bossier City, Louisiana; and Boomtown Reno in Reno, Nevada. The company also operates River Downs racetrack in southeast Cincinnati, Ohio. As of May 26, 2011, it operated seven casinos and one racetrack. The company was formerly known as Hollywood Park, Inc. and changed its name to Pinnacle Entertainment, Inc. in February 2000. Pinnacle Entertainment, Inc. was founded in 1935 and is based in Las Vegas, Nevada.

Advisors' Opinion:

• [By Grace L. Williams]

  First up is Pinnacle Entertainment (PNK). CEO Anthony Michaal Sanfilippo bought 23,000 shares of the Las Vegas-based gaming company for $505,800. InsiderScore notes this is his first purchase in nearly two years and writes, ��fter shares retreated more than 15% from a six-year high and with an activist hedge fund pushing the casino operator to spin off its real estate into a REIT, Sanfilippo stepped up with his first purchase. [He put] a fresh $500,000 into the stock at a price two times his cost basis of previous buys.��/p>

• [By Ben Levisohn]

  Pinnacle Entertainment (PNK) has gained 56% this year; Las Vegas Sands (LVS) has climbed 38%. And Deutsche Bank has nice things to say about both today.

  Bloomberg

  First Pinnacle. Deutsche Bank’s Carlo Santarelli ponders the stock’s big move and comes away still seeing value in its shares. He writes:

  When we upgraded PNK in April, our thesis centered on the FCF strength of the combined entities [Pinnacle completed its acquisition of Ameristar Casinos on Aug. 14], a handful of favorable catalysts, easing regional gaming comps, & an inexpensive relative valuation. Given the shares’ sizeable move since then, we believe it is worth revisiting the investment case. Post the announcement of several asset sales and the closing of the transaction, we are adjusting our estimates, raising our PT to $30 from $24, and maintaining our bullish view at current levels given what we still believe to be an attractive free cash flow valuation, meaningful potential synergy realization beyond the $40 mm of announced benefits, and a free option on a lagging regional recovery.

  Santarelli also revisited Las Vegas Sands and there too, he likes what he sees. He writes:

  With…LVS at [a share price level] that have been challenging to break from over the last year plus, we believe this time is different and hence we see continued upward momentum…In the case of LVS, we see; 1) meaningful mass market strength continuing through year end, setting the stage for upward company and market estimate revisions for 2014, 2) continued cash flow appreciation and capital returns serving as downside protection and positive catalysts, and 3) continued shared gains, largely driven by table optimization and mass market strength, driving both estimates and sentiment.

  He also likes Wynn Resorts (WYNN), despite its 34% gain.�Santarelli writes:

  As for WYNN, we believe near-term estimates continue to take a back seat to capital return

• [By Sean Williams]

  Time to make the switch
  If I could name a sector that I'd certainly tread lightly around considering that consumers are tightening their wallets, it would be the casino sector. Casino companies rely on loose wallets and vacations to drive profits. This is why I feel it could be the time to say goodbye to casino and race track operator Pinnacle Entertainment (NYSE: PNK  ) near its 52-week high.

• [By Dan Radovsky]

  Pinnacle Entertainment (NYSE: PNK  ) has reached an agreement in principle with the Bureau of Competition of the Federal Trade Commission that would allow the company to complete its proposed acquisition of Ameristar Casinos (NASDAQ: ASCA  ) , Pinnacle announced today.

Best Casino Stocks To Invest In 2014: Monarch Casino & Resort Inc (MCRI)

Monarch Casino & Resort, Inc. (Monarch), incorporated in 1993, through its wholly owned subsidiary, Golden Road Motor Inn, Inc. (Golden Road), owns and operates the Atlantis Casino Resort Spa(the Atlantis), a hotel/casino facility in Reno, Nevada. Monarch�� other wholly owned subsidiaries, High Desert Sunshine, Inc. (High Desert) and Golden North, Inc. (Golden North), each own separate parcels of land located adjacent to the Atlantis. The Company owns and operates the Atlantis Casino Resort Spa, which is located approximately three miles south of downtown in the area of Reno, Nevada. The Atlantis features approximately 61,000 square feet of casino space; a hotel with 824 guest rooms and suites; ten food outlets; an enclosed year-round pool with waterfall; an outdoor pool; a health spa; two retail outlets offering clothing and resort gift shop merchandise; a full service salon for men and women; an 8,000 square-foot family entertainment center; and approximately 52,000 square feet of banquet, convention and meeting room space. During the year ended December 31, 2011, the Company acquired 1.5 acre parcel of developable land contiguous to the Riviera Black Hawk Casino.

In April 2012, it acquired Riviera Black Hawk, Inc.

The Atlantis Casino offers approximately 1,450 slot and video poker machines; approximately 39 table games, including blackjack, craps, roulette and others; a race and sports book; keno and a poker room. The Atlantis includes three contiguous high-rise hotel towers with 824 rooms and suites. The Atlantis includes three contiguous high-rise hotel towers with a total of 824 rooms and suites. The first of the three hotel towers contains 160 rooms and suites in 13 stories. The 19-story second hotel tower contains 278 rooms and suites. The third tower contains 386 rooms and suites in 28 stories.

The Atlantis hotel rooms feature designs and furnishings consistent with the Northern Nevada market, as well as nine-foot ceilings (most standard hotel rooms have eig! ht-foot ceilings), which create an open and spacious feel. The third hotel tower features a four-story waterfall with an adjacent year-round swimming pool in a climate controlled, five-story glass enclosure, which shares an outdoor third floor pool deck with a seasonal outdoor swimming pool and year round whirlpool. A full-service salon (the Salon at Atlantis) overlooks the third floor sundeck and outdoor seasonal swimming pool and offers salon-grade products and treatments for hair, nails, skincare and body services for both men and women. A health spa is located adjacent to the swimming areas, which offers treatments and amenities. The hotel rooms on the spa floor are designated as spa rooms and feature decor that is themed consistent with the spa. Certain spa treatments are also available in spa floor hotel rooms. The hotel also features glass elevators rising the full 19 and 28 stories, of the respective towers providing views of the Reno area and the Sierra Nevada mountain range.

The Atlantis has eight restaurants, two gourmet coffee bars and one snack bar. It includes 160-seat Atlantis Steakhouse gourmet restaurant; the 200-seat upscale Bistro Napa featuring a centrally located wine cellar; the Oyster Bar restaurant in the Sky Terrace offering fresh seafood, soups and bisques made to order; the Sushi Bar, also in the Sky Terrace, offering a variety of fresh raw and cooked sushi specialties, including all-you-can-eat lunch and dinner selections. The Oyster Bar and Sushi Bar can accommodate up to 139 guests; The 178-seat 24-hour Purple Parrot coffee shop; the 122-seat Cafe Alfresco restaurant serving a full menu, pizzas prepared in a wood-fired, brick oven and a variety of gelato deserts; the 170-seat Manhattan Deli restaurant specializing in piled-high sandwiches, soups, salads and desserts; two gourmet coffee bars, offering specialty coffee drinks, pastries and desserts made fresh daily in the Atlantis bakery; a snack bar and soda fountain serving ice cream and arcade-style refreshmen! ts.

The Sky Terrace is a structure with a diamond-shaped, blue glass body suspended approximately 55 feet, and spanning 160 feet across, South Virginia Street. The Sky Terrace connects the Atlantis with additional parking on its 16-acre site across South Virginia Street from the Atlantis. The structure rests at each end on two 100-foot tall Grecian columns with no intermediate support pillars. The interior of the Sky Terrace contains the Oyster Bar, the Sushi Bar, a video poker bar, banks of slot machines and a lounge area with oversized leather sofas and chairs.

Advisors' Opinion:

• [By Jeremy Bowman]

  What: Shares of Monarch Casino & Resort (NASDAQ: MCRI  ) were cooling off today, falling as much as 20% after the company's earnings report failed to impress.

Top Shipping Stocks To Own Right Now

Top Shipping Stocks To Own Right Now: RRSat Global Communications Network Ltd.(RRST)

RRsat Global Communications Network Ltd. provides content management and distribution services to television and radio broadcasting industries. The company, through its proprietary ?RRsat Global Network? comprising satellite and terrestrial fiber optic transmission capacity and the public Internet, offers distribution services for content providers. Its content distribution services consist of worldwide transmission of video and audio broadcasts. The company also offers content management services, including digital archiving and compilation of customer?s programming and advertising content into various broadcast channels. In addition, RRsat Global Communications Network Ltd. provides various production services on a contractual basis and satellite newsgathering services through its fleet of vans for outside broadcasting and electronic news gathering crews and packages. Further, it offers live broadcast studios and editing facilities to its customers. The company?s RRs at Global Network delivers content to various end markets, including cable operators, satellite operators, Internet protocol television operators, direct to home market, and public Internet. Additionally, RRSat Global Communications Network provides mobile satellite telecommunications services, such as global telephony, fax, data, Internet, and other value added services for shipping, aviation, construction, and oil companies; humanitarian aid organizations; governmental agencies; and other end customers that require telephony and Internet services in remote areas. As of December 31, 2009, it provided services to approximately 545 television and radio channels in approximately 150 countries. The company was founded in 1981 and is headquartered in D.N. Shikmim, Israel.

Advisors' Opinion:

• [By Garrett Cook]

  In trading on Friday, telecommunications services shares were relative leaders, up on the day by about! 0.88 percent. Meanwhile, top gainers in the sector included RRSat Global Communications Network (NASDAQ: RRST), up 3.4 percent, and China Mobile (NYSE: CHL), up 2.3 percent.

source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/top-shipping-stocks-to-own-right-now-4.html

Hot Tech Stocks To Watch Right Now

The U.S. Defense Security Cooperation Agency -- the outfit responsible for coordinating military sales contracts between the U.S. and its allies, and getting Congress' OK on such sales before they can proceed -- notified Congress of no fewer than five such upcoming "foreign military sales" contracts Wednesday. The biggest of the sales involving actual arms was a proposed sale [link opens in PDF] to Kuwait of a single Boeing (NYSE: BA  ) C-17 Globemaster III transport aircraft.

The aircraft, equipped with F117-PW-100 engines from United Technologies (NYSE: UTX  ) subsidiary Pratt & Whitney, is expected to cost approximately $371 million all-in. DSCA told Congress that in addition to securing the revenues for Boeing and UTC, selling this plane to Kuwait is a good idea because "Kuwait continues to be a key ally and strong supporter of U.S. foreign policy and national security goals in the Persian Gulf region. The proposed sale will enhance the United States foreign policy and national security objectives by increasing interoperability among the Kuwait Air Force (KAF), the United States Air Force, Gulf Cooperation Council countries, and other coalition forces."

Top Solar Companies To Invest In Right Now: 3D Systems Corp. (DDD)

3D Systems Corporation, through its subsidiaries, engages in the design, development, manufacture, marketing, and servicing of 3D printers and related products, print materials, and services. The company�s principle print engines comprise stereolithography, selective laser sintering, multi-jet modeling, film transfer imaging, selective laser melting, and plastic jet printers. Its 3D printers convert data input from computer-aided design software or 3D scanning and sculpting devices to produce physical objects from engineered plastic, metal, and composite print materials. The company also blends, markets, sells, and distributes various consumables, engineered plastics, metal materials, and composites; and offers various software tools, as well as pre-sale and post-sale services, including applications development, installation, warranty, and maintenance. In addition, it provides custom parts services, such as precision plastic and metal parts service and assembly capabilit ies. The company markets its stereolithography materials under the Accura and RenShape; laser sintering materials under the DuraForm, CastForm, and LaserForm; and materials for professional printers under the VisiJet brands. It primarily serves manufacturers of automotive, aerospace, computer, electronic, defense, education, consumer, energy and healthcare products, as well as original equipment manufacturers, government agencies, universities, and independent service bureaus. The company sells its products and services through its direct sales organization, sales agents, resellers, and distributors primarily in the United States, Europe, and the Asia-Pacific region. 3D Systems Corporation was founded in 1986 and is headquartered in Rock Hill, South Carolina.

Advisors' Opinion:

• [By Rex Moore]

  In this segment, Sloan explains how 3D Systems' (NYSE: DDD  ) business model differs from competitors like Stratasys (NASDAQ: SSYS  ) .

• [By Nicole Seghetti]

  Aggressive
  These companies potentially cause paradigm shifts, turning an industry totally on its head. Think of the small biotech company that might come up with a cure for cancer. Or consider today's red-hot 3-D printing sector, spurred by a disruptive technology that's reshaping the way the world converts data into physical objects. For example, last year's stock market darling, 3D Systems (NYSE: DDD  ) , returned nearly 248% in 2012! And that might be just the beginning if this exciting technology is adopted widespread.

Hot Tech Stocks To Watch Right Now: Imprimis Pharmaceuticals Inc (IMMY)

Imprimis Pharmaceuticals Inc. is a specialty pharmaceutical company developing non-invasive, topically delivered products. The Company�� Transdel cream formulation technology is designed to facilitate the effective penetration of a variety of products through the tough skin barrier. Ketotransdel, the Company�� lead pain product, utilizes the Transdel platform technology to deliver the active drug, ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), through the skin directly into the underlying tissues where the drug exerts its anti-inflammatory and analgesic effects. Ketotransdel consists of a transdermal formulation of ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), and its Transdel drug delivery system and is being developed for the treatment of acute pain. In July 2013, it acquired intellectual property for IPI-120 from Buderer Drug Company.

Ketotransdel penetrates the skin barrier to reach the targeted underlying tissues where it exerts its localized anti-inflammatory and analgesic effect. Transdel is the Company�� transdermal cream drug delivery platform. It consists of a cream that enables transdermal penetration of drugs avoiding first pass metabolism by the liver and minimizing systemic exposure. The Transdel drug delivery system facilitates the effective dissolution and delivery of a drug across the skin barrier to reach targeted underlying tissues.

Advisors' Opinion:

• [By John Udovich]

  The start of 2014 shows that biotech is still a hot area with the sector along with small cap biotech stocks like AMAG Pharmaceuticals, Inc (NASDAQ: AMAG), Mast Therapeutics Inc (NYSEMKT: MSTX), Cell Therapeutics Inc (NASDAQ: CTIC), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and TNI BioTech (OTCMKTS: TNIB) producing news or returns�plus Auspex Pharmaceuticals (NASDAQ: ASPX), Cara Therapeutics (NASDAQ: CARA), Egalet (NASDAQ: EGLT), Flexion Therapeutics (NASDAQ: FLXN) and Ultragenyx Pharmaceutical (NASDAQ: RARE) are among the (many�� planned biotech IPOs that have recently been announced publicly:

• [By John Udovich]

  So far this year, Rexahn Pharmaceuticals, Inc (NYSEMKT: RNN), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and Arrowhead Research Corp (NASDAQ: ARWR) are up 186.3%, 157.2% and 142.5%, respectively, since the start of the year���making them the best performing small cap biotech stocks for 2014. But given their lackluster performance over the past few years, what is the secret behind their phenomenal 2014 rise and will they keep rising? For starters, none of these small caps have really produced anything in the way of blockbuster news:

Hot Tech Stocks To Watch Right Now: Autodesk Inc.(ADSK)

Autodesk, Inc. provides design software and services to customers worldwide. Its Platform Solutions and Emerging Business segment offers AutoCAD software, a customizable and extensible computer-aided design (CAD) application for professional design, drafting, detailing, and visualization in fields ranging from construction to manufacturing, civil engineering, and process plant design; and AutoCAD LT, a professional drafting and detailing software that includes document sharing capability. The company?s Architecture, Engineering and Construction segment offers Autodesk Revit products, which provide model-based design and documentation system for architects, structural engineers, and design-build teams, as well as mechanical, electrical, and plumbing engineers; AutoCAD Civil 3D products, which provide a surveying, design, analysis, and documentation solution for civil engineering; AutoCAD Architecture software that includes architecture industry-specific tools to improve co ordination; and AutoCAD Map 3D software, which provides direct access to data needed for infrastructure planning, design, and management activities. Autodesk, Inc.?s Manufacturing segment?s products comprise Autodesk Inventor, which offers engineers a set of tools for 3D mechanical design, simulation, analysis, tooling, visualization, and documentation; AutoCAD Mechanical software that accelerates the mechanical design process; and Autodesk Moldflow, which provides tools that help manufacturers optimize the design of plastic parts and injection molds, and study the injection molding process. Its Media and Entertainment segment offers animation products that provide tools for digital sculpting, modeling, animation, effects, rendering, and compositing; and creative finishing products that provide editing, finishing, and visual effects design and color grading. The company also offers design and creation suites. Autodesk, Inc. was founded in 1982 and is headquartered in San R afael, California.

Advisors' Opinion:

• [By Northrop Puckett]

  Autodesk (ADSK), the multinational software company that makes drafting, manufacturing, civil engineering, 3D, and animation design software, has experienced a recent pullback. Part of that is due to the general market correction, but the other part is due to its recent quarterly results. It has pulled back roughly 13% from its high of $41.42 in May. Can it be bought now? Or is there more downside in the stock?

• [By Peter Graham]

  The Q2 2014 earnings report for software stock Adobe Systems Incorporated (NASDAQ: ADBE), a potential peer or performance benchmark of other software stocks or players like Microsoft Corporation (NASDAQ: MSFT), Autodesk, Inc (NASDAQ: ADSK) and iShares S&P GSTI Software Index Fund (NYSEARCA: IGV), is scheduled for after the market closes on Tuesday. Aside from the Adobe Systems Incorporated earnings report, it should be said that Microsoft Corporation reported Q3 2014 earnings on April 24th (FYQ3 revenues and�EPS beat; cloud revenue doubled; Q4 view was light) and Autodesk, Inc reported Q1 2015 earnings on�May 15th (Q1 revenues beat and�earnings met�estimates). The last time Adobe Systems reported earnings, it beat expectations thanks to strong adoption of Creative Cloud and Adobe Marketing Cloud as the�company has been shifting away from from physical products to cloud-based software that users subscribe to.

• [By Geoff Gannon]

  I was looking at the fundamental of 18 stocks; I own 5 of them: Apple (AAPL), Abbott Laboratories (ABT), Autodesk (ADSK), Cisco (CSCO) and Exelon (EXC). Others were ideas collected from places like news, etc.

• [By Damian Illia]

  In order to answer these interrogations, I will look into Nuance and Autodesk (ADSK), and try elucidate which one stands as the most appealing investment opportunity.

Hot Tech Stocks To Watch Right Now: SemiLEDS Corporation(LEDS)

SemiLEDs Corporation engages in the development, manufacture, and sale of light emitting diode (LED) chips and LED components. Its products are used primarily for general lighting applications, including street lights and commercial, industrial, and residential lighting, as well as in backlighting, medical, automotive, and ultra violet (UV) applications. The company markets blue, green, and UV LED chips under the MvpLED brand name primarily to customers in China and Taiwan, as well as in Russia and North America. It sells LED chips to packagers and distributors, who in turn sell to packaging customers. SemiLEDs Corporation was founded in 2005 and is based in Miao-Li County, Taiwan.

Advisors' Opinion:

• [By Paul Ausick]

  Just a week earlier SemiLEDS Corp. (NASDAQ: LEDS) said that it had received a delisting notice from Nasdaq for failing to maintain a share price of at least $1 a share. The company also faced several class action lawsuits as earnings tanked after a dramatic run-up in April. Shares rose nearly 15% after Revolution�� October announcement.

Hot Tech Stocks To Watch Right Now: Motorola Solutions Inc (MSI)

Motorola Solutions, Inc. (Motorola Solutions), incorporated March 9, 1973, provides communication infrastructure, devices, software and services. The Company provides these products and services for enterprise and government customers worldwide. The Company operates in two segments: Government and Enterprise. The Government segment includes sales of public safety communications systems, commercial two-way radio systems and devices, software and services. The Enterprise segment includes sales of rugged and enterprise-grade mobile computers and tablets, laser/imaging/RFID-based data capture products, wireless local area network (WLAN) and integrated digital enhanced network (iDEN) infrastructure, software and services. In January 2014, the Company announced that it has acquired Twisted Pair Solutions, a provider of push-to-talk over broadband applications for secure, real-time communication anywhere, on any device.

Government

The Government segment designs, manufactures, sells, and provides services around voice and data communications systems, devices, security products and applications. These products and services are sold to a range of customers, including government, public safety and first responder agencies, as well as commercial customers who operate private communications networks and manage a mobile workforce.

The Company offer a portfolio of network infrastructure, devices, applications and services, based on Association for Public Safety Communications Officials 25 (APCO), terrestrial trunked radio (TETRA), and digital mobile radio (DMR) standards, as well as broadband technologies (Long-Term Evolution (LTE) and WiFi). Its products and services are sold stand alone, as well as part of an integrated system. In addition, Motorola Solutions offer critical applications in the public safety command center, including voice, computer aided dispatch and multimedia/video. The Company�� service offering includes mobility consulting, system design and installatio! n, network and device management and product support.

The Company competes with Cassidian/EADS, Harris, Hytera, Kenwood, Sepura and Tait.

Enterprise

The Enterprise segment designs, manufactures, sells and provides services around WLAN infrastructure, rugged and enterprise-grade advanced data capture and mobile computing devices, security products and applications. These are sold to a range of enterprise customers, including those in retail and hospitality, transportation and logistics, manufacturing, energy and utilities, education and healthcare. Motorola Solutions offers a portfolio of devices, infrastructure, applications and services, which include rugged and enterprise-grade mobile computers and tablets, laser/imager/RFID based data capture devices and kiosks, WLAN switches/controllers and access points, network and device management software, network and device security software, voice-based devices and software, and systems based iDEN technology.

The Company competes with Apple, Aruba, Bluebird, Cisco, Datalogic, Honeywell, Hewlett Packard, Intermec, Psion, Panasonic and Samsung.

Advisors' Opinion:

• [By Selena Maranjian]

  More than a handful of Guru-approved companies had strong performances over the past year. Hartford Financial Services Group (NYSE: HIG  ) and Motorola Solutions (NYSE: MSI  ) each surged 31%. Hartford has been shifting its focus from annuities, retirement planning, and life insurance toward property and casualty insurance. It has been tackling its significant debt, and its fourth-quarter earnings exceeded expectations. The stock has exhibited volatility, but some see it as undervalued now, with a forward P/E ratio of just 8.

• [By James Brumley]

  If the idea of Carl Icahn wanting to split a company up seems vaguely familiar, too … well, that’s hardly anything new, either. Icahn was the key driver behind Transocean (RIG) opting to divest some of its master limited partnership holdings, he desperately wanted OshKosh (OSK) to spin off JLG, and somehow Icahn got credit for sparking Motorola’s (MSI) spinoff of its mobile phone business.

Hot Tech Stocks To Watch Right Now: Compucon Computer Applications SA (COMP)

Compucon Computer Applications SA is a Greek company engaged mainly in the information technology sector. The Company's activities include the manufacture and trade of electronics and software for the embroidery, telematics, laser, Web solutions and medical fields. In the embroidery field it offers album presentation or embroidery designs, lettering with a variety of fonts, frames and specialized features, and realistic three-dimensional views of embroidery designs. The Company also produces laser cutting and engraving devices for the embroidery sector. The range of telematics applications includes automotive positioning systems, fleet management and navigation systems. Its Web solutions offering includes the SiteCosmos, which is an integrated tool for on-line content management and Website design for small and medium enterprises, while the medical applications target the management of patient-oriented information, diet schedules, word processing, prescriptions and other services. Advisors' Opinion:

• [By Anora Mahmudova]

  The Nasdaq Composite (COMP) �finished the day up 4.53 points, or 0.1%, at 4,155.76. The tech-heavy index is down 2.8% for the week, its worst performance since Oct 2012.

• [By Benjamin Pimentel]

  The start of a new week with the federal government still shut down sent stocks falling in early trades, but the Nasdaq Composite Index (COMP) �recovered, rising 0.6% to close at 3,815.27. The Dow Jones Industrial Average (DJIA) �also turned positive, closing up 0.4% on news of a possible budget deal in Washington D.C.

• [By Anora Mahmudova]

  The Nasdaq Composite (COMP) �added 39.91 points, or 1%, to 4,161.46, recording the sixth consecutive session of gains, helped by a 6% rally in Netflix, Inc. Biotechnology and pharmaceutical companies also jumped. Both the Nasdaq Biotechnology index (NBI) � and the iShares Nasdaq Biotechnology ETF (IBB) � rose 3.2%.

• [By Wallace Witkowski]

  Last week, the Nasdaq Composite Index (COMP) rose 0.5%. It�� moved between weekly gains and losses for six straight weeks.

Top 5 Mid Cap Stocks For 2014

On Monday, small cap molecular diagnostic stock Myriad Genetics, Inc (NASDAQ: MYGN) suddenly sank 9.34% to $23.50 just before the market closed���meaning its probably a good idea to take a closer look at what happened yesterday plus compare the stock�� performance verses small cap peer Sequenom, Inc (NASDAQ: SQNM) and mid cap peer Hologic, Inc (NASDAQ: HOLX).�

What is Myriad Genetics?

Small cap Myriad Genetics is a molecular diagnostic company focused on the discovery and commercialization of transformative tests to assess a person�� risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence. At the moment, Myriad Genetics has nine innovative products, a�390-strong sales force and thirteen pipeline tests in development.

Best Industrial Conglomerate Companies To Invest In 2015: Perceptron Inc.(PRCP)

Perceptron, Inc. develops, produces, and sells non-contact measurement and inspection solutions in the Americas, Europe, and Asia. It offers AutoGauge systems that are used in the assembly and fabrication plants of automotive manufacturers; AutoGauge Plus, which offers freeform surface scanning and discrete feature measurement in one solution; AutoFit systems that are used in automotive manufacturing plants to contain, correct, and control the fit of exterior body panels; AutoScan systems, which provide a non-contact method of gathering data for the analysis of the surface contour of a part or product; and AutoGuide systems to calculate the difference between theoretical and actual relationships of a robot and the part being assembled, and send compensation data in six degrees of freedom to the robot. The company also offers ScanWorks, a hardware/software component set that allows customers to add digitizing capabilities to their machines or systems; ScanWorks xyz, a 3D sc anning solution designed for retrofitting 3-axis machines; ToolKit, a software solution for CMM manufacturers, system integrators, and application software developers; WheelWorks software and sensors that offer a non-contact method of measuring wheel position for use in automated or manual wheel alignment machines in automotive assembly plants; and Multi-line Sensors for use in automotive assembly plant wheel alignment systems. In addition, it manufactures visual inspection devices and accessories for the mechanical market; plumbing diagnostic equipment, meter imager systems, line detector accessories, and handheld inspection devices for the plumbing market; optical inspection devices for the construction and DIY market; and imaging solutions for the electrical market, as well as offers value-added services, including training, field services, launch support, consulting, maintenance agreements, repairs, and software tools. The company was founded in 1981 and is headquartered in Plymouth, Michigan.

Advisors' Opinion:

• [By Garrett Cook]

  In trading on Tuesday, industrials shares were relative leaders, up on the day by about 0.26 percent. Top gainers in the sector included Perceptron (NASDAQ: PRCP), up 10.9 percent, China Ming Yang Wind Power Group (NYSE: MY), up 4.8 percent.

Top 5 Mid Cap Stocks For 2014: Primero Mining Corp (PPP)

Primero Mining Corp. (Primero) is a precious metals producer with operations in Mexico. The Company is focused on precious metals assets in the Americas through acquiring, exploring, developing and operating mineral resource properties. As of December 31, 2011, Primero had one producing property, the San Dimas Mine, located in Mexico�� San Dimas district, on the border of Durango and Sinaloa states, and one exploration property, Ventanas, located in Durango state, Mexico. The San Dimas Mine consists of three underground gold and silver mining operations at Tayoltita, San Antonio (Central Block) and Santa Rita. In 2011, the San Dimas Mine produced 79,564 ounces of gold and 4.6 million ounces of silver. Primero also holds 28 mining concessions (3,470.4 hectares) at Mala Noche-Ventanas-San Cayetano (the Ventanas Project). Primero has three active, wholly owned subsidiaries include Primero Empresa Minera, S.A. de C.V., Silver Trading (Barbados) Ltd. and Primero Mining Luxembourg s.a r.l. Advisors' Opinion:

• [By MONEYMORNING]

  As well, Primero Mining (NYSE: PPP) bought Brigus Gold Corp (USA)(NYSE: BRD) for $220 million, and Asanko Gold (NYSEMKT: AKG) is acquiring PMI Gold Corporation (TSE: PMV).

Top 5 Mid Cap Stocks For 2014: CVR Energy Inc (CVI)

CVR Energy, Inc. (CVR Energy), incorporated September 2006, through its wholly owned subsidiaries, acts as an independent petroleum refiner and marketer of transportation fuels in the mid-continental United States. In addition, the Company, through its majority-owned subsidiaries, acts as an independent producer and marketer of nitrogen fertilizer products in North America. As of December 31, 2011, the Company owned the general partner and approximately 70% of CVR Partners, LP (the Partnership), a limited partnership which produces nitrogen fertilizers in the form of ammonia and an aqueous solution of urea and ammonium nitrate used as a fertilizer (UAN). The Company operates in two segments: the petroleum segment and the nitrogen fertilizer segment. On December 15, 2011, the Company acquired Gary-Williams Energy Corporation and its subsidiaries (GWEC).

Petroleum Business

The Company operates a 115,000 barrels per day complex full coking medium-sour crude oil refinery in Coffeyville, Kansas and, as of December 15, 2011, a 70,000 barrels per day crude oil unit refinery in Wynnewood, Oklahoma. Its combined production capacity represents approximately 15% of its region's output during the year ended December 31, 2011. The Coffeyville facility is situated on approximately 440 acres in southeast Kansas, approximately 100 miles from Cushing, Oklahoma, a crude oil trading and storage hub. The Wynnewood facility is situated on approximately 400 acres located approximately 65 miles south of Oklahoma City, Oklahoma and approximately 130 miles from Cushing, Oklahoma. During 2011, its Coffeyville refinery's product yield included gasoline (mainly regular unleaded) (44%), diesel fuel (42%), and pet coke and other refined products, such as natural gas liquids (NGL) (propane and butane), slurry, sulfur and gas oil (14%). Its Wynnewood refinery's product yield included gasoline (54%), diesel fuel (31%), asphalt (6%), jet fuel (3%) and other products (6%) during 2011.

The Company! owns and operates a crude oil gathering system serving Kansas, Oklahoma, western Missouri and southwestern Nebraska. The system has field offices in Bartlesville, Oklahoma, Plainville, Kansas and Winfield, Kansas. The system consists of approximately 350 miles of feeder and trunk pipelines, 100 trucks, and associated storage facilities for gathering sweet crude oils purchased from independent crude oil producers in Kansas, Nebraska, Oklahoma and Missouri. It also leases a section of a pipeline from Magellan Midstream Partners, L.P. (Magellan), which is incorporated into its crude oil gathering system. During 2011, the Company�� crude oil gathering system had a gathering capacity of approximately 38,000 barrels per day. During 2011, it gathered an average of approximately 35,000 barrels per day.

CVR Energy owns a pipeline system capable of transporting approximately 145,000 barrels per day of crude oil from Caney, Kansas to its refinery. Crude oils sourced outside of its gathering system are delivered by common carrier pipelines into various terminals in Cushing, Oklahoma, where they are blended and then delivered to Caney, Kansas via a pipeline owned by Plains Pipeline L.P. (Plains). The Company also owns associated crude oil storage tanks with a capacity of approximately 1.2 million barrels located outside its Coffeyville refinery, 0.5 million barrels of crude oil storage at Wynnewood, Oklahoma, and lease an additional 3.3 million barrels of storage capacity located at Cushing, Oklahoma and other locations. In addition to crude oil storage, it owns approximately 4.5 million barrels of combined refinery related storage capacity.

CVR Energy has access to foreign crude oil from Latin America, South America, West Africa, the Middle East, the North Sea and Canada. It purchases domestic crude oil from Kansas, Oklahoma, Nebraska, Texas, North Dakota, Missouri, and offshore deepwater Gulf of Mexico production. During 2011, its Coffeyville crude oil supply blend consisted of approx! imately 8! 0% light sweet crude oil, 2% light/medium sour crude oil and 18% heavy sour crude oil. During 2011, Wynnewood's crude oil supply blend consisted of approximately 88% sweet crude oil and 12% light/medium sour crude oil.

During 2011, approximately 35% of the Coffeyville refinery's products were sold through the rack system directly to retail and wholesale customers, while the remaining 65% was sold through pipelines via bulk spot and term contracts. The Company makes bulk sales (sales into third party pipelines) into the mid-continent markets via Magellan and into Colorado and other destinations utilizing the product pipeline networks owned by Magellan, Enterprise Products Operating, L.P. (Enterprise) and NuStar Energy, LP (NuStar). Approximately 60% of the Wynnewood refinery's finished products sold are distributed in Oklahoma. Customers for its petroleum products include other refiners, convenience store companies, railroads and farm cooperatives.

The Company competes with BP, Conoco Phillips, HollyFrontier, NCRA, Valero, Flint Hills Resources, CHS and Shell.

Nitrogen Fertilizer Business

The nitrogen fertilizer business, operated by the Partnership, is the nitrogen fertilizer plant in North America. It utilizes a pet coke gasification process to produce nitrogen fertilizer. The nitrogen fertilizer facility's primary input is pet coke. The nitrogen fertilizer facility includes a 1,225 ton-per-day ammonia unit, a 2,025 ton-per-day UAN unit and a gasifier complex having a capacity of 84 million standard cubic feet per day. Linde LLC (Linde) owns, operates, and maintains the air separation plant that provides contract volumes of oxygen, nitrogen and compressed dry air to the gasifier for a monthly fee.

The primary geographic markets for the nitrogen fertilizer business' fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado and Texas. The nitrogen fertilizer business markets the ammonia products to industrial and agricu! ltural cu! stomers and the UAN products to agricultural customers. The nitrogen fertilizer business sells ammonia to agricultural and industrial customers. Agricultural customers include distributors such as MFA, United Suppliers, Inc., Brandt Consolidated Inc., Gavilon Fertilizer LLC, Transammonia, Inc., Agri Services of Brunswick, LLC, Interchem and CHS Inc. Industrial customers include Tessenderlo Kerley, Inc., National Cooperative Refinery Association, and Dyno Nobel, Inc. The nitrogen fertilizer business sells UAN products to retailers and distributors.

The Company competes with Agrium, Koch Nitrogen, Potash Corporation and CF Industries.

Advisors' Opinion:

• [By Charles Sizemore]

  Charles here: Behind the Numbers included one MLP in particular��arl Icahn�� holding company Icahn Enterprises LP (IEP) that is not at all a pipeline MLP, though it does have indirect exposure to energy prices via some of its portfolio holdings, such as CVR Energy (CVI). It also has exposure to energy via its ownership interest in Icahn�� hedge fund, which in turn has large positions in Chesapeake Energy (CHK)and other energy-related companies. Icahn, incidentally, had a terrible third quarter, driven, in his own words, ��y a meaningful decrease in the value of our core energy investments.��For my recent comments on Icahn��nd what he�� doing right��ee Why Carl Icahn is (Kinda) Right About Apple.

Top 5 Mid Cap Stocks For 2014: Saks Incorporated(SKS)

Saks Incorporated operates retail stores in the United States. Its stores offer an assortment of fashion apparel, shoes, accessories, jewelry, cosmetics, and gifts. The company operates stores under the brand name of Saks Fifth Avenue (SFA) that are principally free-standing stores in shopping destinations or anchor stores in upscale regional malls. It also operates Saks Fifth Avenue OFF 5TH (OFF 5TH) stores, which are primarily located in upscale mixed-use and off-price centers. As of January 28, 2012, the company operated 46 SFA stores; and 60 OFF 5TH stores. Saks Incorporated also sells its products online at saks.com, as well as through catalogs. The company was founded in 1919 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Rich Duprey]

  The own of upscale retailer Lord & Taylor is adding another luxury nameplate to its portfolio. Canadian shop Hudson's Bay will buy Saks (NYSE: SKS  ) , the two retailers jointly announced, in a deal valued at about $2.9 billion, including debt.

• [By Paul Ausick]

  The only earnings reports of note since last Friday came from Saks Inc. (NYSE: SKS) which is trading down 0.2% at $15.99.

  Before markets open Tuesday morning we are scheduled to hear results from Perfect World Co. Ltd. (NASDAQ: PWRD), Urban Outfitters Inc. (NASDAQ: URBN), Barnes & Noble Inc. (NYSE: BKS) which announced a new video app today, Best Buy Co. Inc (NYSE: BBY) which is included in our preview of this week�� results from retailers, Dick�� Sporting Goods Inc. (NYSE: DKS), Home Depot Inc. (NYSE: HD), J.C. Penney Co. Inc. (NYSE: JCP), and Trina Solar Ltd. (NYSE: TSL).

• [By Andrew Marder]

  For a company that is putting up solid sales growth, has a great brand, and has seen its stock price rise more than 40% in the last 12 months, Saks (NYSE: SKS  ) didn't demand much of a premium. Hudson's Bay, the operator behind Lord & Taylor, picked up Saks for just $16 per share, representing a 4.5% bump to Friday's closing price.

Hot Value Stocks To Own Right Now

Hot Value Stocks To Own Right Now: Schlumberger N.V.(SLB)

Schlumberger Limited, together with its subsidiaries, supplies technology, integrated project management, and information solutions to the oil and gas exploration and production industries worldwide. The company?s Oilfield Services segment provides exploration and production services; wireline technology that offers open-hole and cased-hole services; supplies engineering support, directional-drilling, measurement-while-drilling, and logging-while-drilling services; and testing services. This segment also offers well services; supplies well completion services and equipment; artificial lift; data and consulting services; geo services; and information solutions, such as consulting, software, information management system, and IT infrastructure services that support oil and gas industry. Its WesternGeco segment provides reservoir imaging, monitoring, and development services; and operates data processing centers and multiclient seismic library. This segment also offers variou s services include 3D and time-lapse (4D) seismic surveys to multi-component surveys for delineating prospects and reservoir management. The company?s M-I SWACO segment supplies drilling fluid systems to improve drilling performance; fluid systems and specialty tools to optimize wellbore productivity; production technology solutions to maximize production rates; and environmental solutions that manages waste volumes generated in drilling and production operations. Its Smith Oilfield segment designs, manufactures, and markets drill bits and borehole enlargement tools; and supplies drilling tools and services, tubular, completion services, and other related downhole solutions. The company?s Distribution segment markets pipes, valves, and fittings, as well as mill, safety, and other maintenance products. This segment also provides warehouse management, vendor integration, and inventory m! anagement services. Schlumberger Limited was founded in 1927 and is based in Houston, Texas .

Advisors' Opinion:

• [By Ben Levisohn]

  Stocks with low turnover include Philip Morris International (PM), Schlumberger (SLB), Johnson & Johnson (JNJ), General Electric (GE) and Automatic Data Processing (ADP).

• [By Ben Levisohn]

  We see several potential sources of continued activity as: (i) Schlumberger (SLB) may look to recapture #1 spot in revenues if Halliburton/Baker Hughes do merge; (ii) Halliburton/Baker Hughes may look to plug their seismic service gap (seismic has been the worst-performing industry sub-segment this year); (iii) Halliburton/Baker Hughes may be forced to divest US assets in order to pass antitrust review. Other potential buyers could include oilfield pure-plays, which may be looking to shift exposure away from offshore rigs and more towards completion/production technologies, or large diversified industrials seeking to capitalize on their strong relative share price performance vs. the energy industry.

source from Top Stocks For 2015:http://www.topstocksblog.com/hot-value-stocks-to-own-right-now-3.html